1,093
Views
25
CrossRef citations to date
0
Altmetric
Original Articles

Statistical Evaluation of Several Methods for Cut-Point Determination of Immunogenicity Screening Assay

, &
Pages 269-279 | Received 03 Oct 2014, Accepted 06 Oct 2014, Published online: 25 Feb 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Qi Xia, Yi Tsong & Yu-Ting Weng. (2020) Methods and applications of percentile estimation. Journal of Biopharmaceutical Statistics 30:2, pages 267-276.
Read now
Xiaoyu Dong, Yi Tsong & Meiyu Shen. (2015) Statistical Considerations in Setting Product Specifications. Journal of Biopharmaceutical Statistics 25:2, pages 280-294.
Read now

Articles from other publishers (23)

Dong Xiang, Ninghong Li, Lu Liu, Hengyi Yu, Xiping Li, Tinghui Zhao, Dong Liu & Xuepeng Gong. (2023) Development and validation of enzyme-linked immunosorbent assays for the measurement of infliximab and anti-drug antibody levels. Heliyon 9:11, pages e21858.
Crossref
Jorge Quiroz, Satrajit Roychoudhury, Thomas Steinmetz & Harry Yang. (2023) Modeling immunogenecity data to establish screening bioassays cut point. Pharmaceutical Statistics 22:6, pages 978-994.
Crossref
Heather Myler, João Pedras-Vasconcelos, Todd Lester, Francesca Civoli, Weifeng Xu, Bonnie Wu, Inna Vainshtein, Linlin Luo, Mohamed Hassanein, Susana Liu, Swarna Suba Ramaswamy, Johanna Mora, Jason Pennucci, Fred McCush, Amy Lavelle, Darshana Jani, Angela Ambakhutwala, Daniel Baltrukonis, Breann Barker, Rebecca Carmean, Shan Chung, Sheng Dai, Stephen DeWall, Sanjay L. Dholakiya, Robert Dodge, Deborah Finco, Haoheng Yan, Amanda Hays, Zheng Hu, Cynthia Inzano, Lynn Kamen, Ching-Ha Lai, Erik Meyer, Robert Nelson, Amrit Paudel, Kelli Phillips, Marie-Eve Poupart, Qiang Qu, Mohsen Rajabi Abhari, Janka Ryding, Curtis Sheldon, Franklin Spriggs, Dominic Warrino, Yuling Wu, Lin Yang & Stephanie Pasas-Farmer. (2023) Neutralizing Antibody Validation Testing and Reporting Harmonization. The AAPS Journal 25:4.
Crossref
Yanshan Dai, Huijin Dong, Carol Gleason, Johanna Mora, Gerry Kolaitis, Nanda Balasubramanian, Sekhar Surapaneni, Alexander Kozhich & Vibha Jawa. (2023) Comparison of Pre-existing Anti-AAV8 Total Antibody Screening and Confirmatory Assays with a Cell-Based Neutralizing Assay in Normal Human Serum. The AAPS Journal 25:3.
Crossref
Jialiang Du, Yalan Yang, Lingling Zhu, Shaoyi Wang, Chuanfei Yu, Chunyu Liu, Caifeng Long, Baowen Chen, Gangling Xu, Linglong Zou & Lan Wang. (2023) Method validation of a bridging immunoassay in combination with acid-dissociation and bead treatment for detection of anti-drug antibody. Heliyon 9:3, pages e13999.
Crossref
JoAnn L. Yee, Richard Grant, Andrew J. Haertel, Carolina Allers, Amanda B. Carpenter, Koen K. A. Van Rompay & Jeffrey A. Roberts. (2022) Multi‐site proficiency testing for validation and standardization of assays to detect specific pathogen‐free viruses, coronaviruses, and other agents in nonhuman primates . Journal of Medical Primatology 51:4, pages 234-245.
Crossref
Amy Lavelle & Megan Wiberg. 2022. Bioanalytical Aspects in Biological Therapeutics. Bioanalytical Aspects in Biological Therapeutics 327 353 .
Heather Myler, João Pedras-Vasconcelos, Kelli Phillips, Charles Scott Hottenstein, Paul Chamberlain, Viswanath Devanaryan, Carol Gleason, Joanne Goodman, Marta Starcevic Manning, Shobha Purushothama, Susan Richards, Honglue Shen, Jad Zoghbi, Lakshmi Amaravadi, Troy Barger, Steven Bowen, Ronald R. Bowsher, Adrienne Clements-Egan, Dong Geng, Theresa J. Goletz, George R. Gunn, William Hallett, Michael E. Hodsdon, Brian M. Janelsins, Vibha Jawa, Szilard Kamondi, Susan Kirshner, Daniel Kramer, Meina Liang, Kathryn Lindley, Susana Liu, ZhenZhen Liu, Jim McNally, Alvydas Mikulskis, Robert Nelson, Mohsen Rajabi Ahbari, Qiang Qu, Jane Ruppel, Veerle Snoeck, An Song, Haoheng Yan & Mark Ware. (2021) Anti-drug Antibody Validation Testing and Reporting Harmonization. The AAPS Journal 24:1.
Crossref
Gregor Jordan & Roland F. Staack. (2021) An Alternative Data Transformation Approach for ADA Cut Point Determination: Why Not Use a Weibull Transformation?. The AAPS Journal 23:5.
Crossref
Anna Laurén, Joanne Goodman, Jonas Blaes, John Cook, Kyra J Cowan, Madeleine Dahlbäck, Joanna Grudzinska-Goebel, Deborah McManus, Robert Nelson, Susanne Pihl & Philip Timmerman. (2021) A strategic approach to nonclinical immunogenicity assessment: a recommendation from the European Bioanalysis Forum. Bioanalysis 13:7, pages 537-549.
Crossref
Meiyu Shen & Tianjiao Dai. (2021) Statistical methods of screening cut point determination in immunogenicity studies. Bioanalysis 13:7, pages 551-563.
Crossref
Susan Spitz, Yan Zhang, Sally Fischer, Kristina McGuire, Ulrike Sommer, Lakshmi Amaravadi, Abbas Bandukwala, Steven Eck, Fabio Garofolo, Rafiqul Islam, Gregor Jordan, Lindsay King, Yoshiro Saito, Giane Sumner, Linda Terry, Alessandra Vitaliti, Yow-Ming Wang, Christine Grimaldi, Alison Joyce, Rachel Palmer, Matthew Andisik, Marcela Araya, Mitra Azadeh, Daniel Baltrukonis, Rebecca Elliott, Sam Haidar, Seema Kumar, Andrew Mayer, Florian Neff, Nisha Palackal, Kun Peng, Mohsen Rajabi Abhari, Christina Satterwhite, Natasha Savoie, Catherine Soo, Stephen Vinter, Jan Welink, Weili Yan, Kevin Maher, David Lanham, Sylvie Bertholet, Naveen Dakappagari, Christèle Gonneau, Cherie Green, Fabian Junker, Sumit Kar, Lisa Patti-Diaz, Shyam Sarikonda, Megan McCausland, Priscila Camillo Teixeira, Vilma Decman, Jose Estevam, Michael Hedrick, Alberto Hidalgo Robert, Gregory Hopkins, Sandra Nuti, Shabnam Tangri, Richard Wnek, Suman Dandamudi, Arindam Dasgupta, Anna Edmison, Patrick Faustino, Michael McGuinness, Gustavo Mendes Lima Santos, Tahseen Mirza, Diaa Shakleya, Susan Stojdl, Nilufer Tampal, Jinhui Zhang, Elana Cherry, Isabelle Cludts, Andrew Exley, Akiko Ishii-Watabe, Susan Kirshner, Joao Pedras-Vasconcelos, Meiyu Shen, Richard Siggers, Therese Solstad, Daniela Verthelyi, Haoheng Yan & Lucia Zhang. (2021) 2020 White Paper on Recent Issues in Bioanalysis: BAV Guidance, CLSI H62, Biotherapeutics Stability, Parallelism Testing, CyTOF and Regulatory Feedback ( Part 2A – Recommendations on Biotherapeutics Stability, PK LBA Regulated Bioanalysis, Biomarkers Assays, Cytometry Validation & Innovation Part 2B – Regulatory Agencies’ Inputs on Bioanalysis, Biomarkers, Immunogenicity, Gene & Cell Therapy and Vaccine) . Bioanalysis 13:5, pages 295-361.
Crossref
Long Yuan, Carol R Gleason, Dennis Stocker, Li Li, Jim X Shen & Qin C Ji. (2021) A bridging immunogenicity assay for anti-cabiralizumab antibodies: overcoming the low assay cut point and drug tolerance challenges. Bioanalysis 13:5, pages 395-407.
Crossref
Xuemin Chen, Larry J. Anderson, Christina A. Rostad, Lingmei Ding, Lilin Lai, Mark Mulligan, Nadine Rouphael, Muktha S. Natrajan, Courtney McCracken & Evan J. Anderson. (2021) Development and optimization of a Zika virus antibody-dependent cell-mediated cytotoxicity (ADCC) assay. Journal of Immunological Methods 488, pages 112900.
Crossref
Imad Baaklini, Conrado de Campos Gonçalves, Gergely L. Lukacs & Jason C. Young. (2020) Selective Binding of HSC70 and its Co-Chaperones to Structural Hotspots on CFTR. Scientific Reports 10:1.
Crossref
Steven Piccoli, Devangi Mehta, Alessandra Vitaliti, John Allinson, Shashi Amur, Steve Eck, Cherie Green, Michael Hedrick, Shirley Hopper, Allena Ji, Alison Joyce, Virginia Litwin, Kevin Maher, Joel Mathews, Kun Peng, Afshin Safavi, Yow-Ming Wang, Yan Zhang, Lakshmi Amaravadi, Nisha Palackal, Sai Thankamony, Chris Beaver, Eris Bame, Thomas Emrich, Christine Grimaldi, Jonathan Haulenbeek, Alison Joyce, Vellalore Kakkanaiah, David Lanham, Kevin Maher, Andrew Mayer, Paul C Trampont, Laurent Vermet, Naveen Dakappagari, Catherine Fleener, Fabio Garofolo, Cynthia Rogers, Shabnam Tangri, Yuanxin Xu, Meina Liang, Manoj Rajadhyaksha, Susan Richards, Becky Schweighardt, Shobha Purushothama, Daniel Baltrukonis, Jochen Brumm, Elana Cherry, Jason Delcarpini, Carol Gleason, Susan Kirshner, Robert Kubiak, Luying Pan, Michael Partridge, João Pedras-Vasconcelos, Qiang Qu, Venke Skibeli, Therese Solstad Saunders, Roland F Staack, Kay Stubenrauch, Al Torri, Daniela Verthelyi, Haoheng Yan, Boris Gorovits, Rachel Palmer, Mark Milton, Brian Long, Bart Corsaro, Vahid Farrokhi, Michele Fiscella, Neil Henderson, Vibha Jawa, Jim McNally, Rocio Murphy, Hanspeter Waldner & Tong-Yuan Yang. (2019) 2019 White Paper on Recent Issues in Bioanalysis: FDA Immunogenicity Guidance, Gene Therapy, Critical Reagents, Biomarkers and Flow Cytometry Validation (Part 3 – Recommendations on 2019 FDA Immunogenicity Guidance, Gene Therapy Bioanalytical Challenges, Strategies for Critical Reagent Management, Biomarker Assay Validation, Flow Cytometry Validation & CLSI H62). Bioanalysis 11:24, pages 2207-2244.
Crossref
Jochen Brumm & Kun Peng. (2019) Evaluation of in-study cut points to enable appropriate interpretation of clinical immunogenicity results. Bioanalysis 11:17, pages 1539-1541.
Crossref
Heather Myler, Boris Gorovits, Kelli Phillips, Viswanath Devanarayan, Adrienne Clements-Egan, George R. Gunn, Susan Kirshner, Binodh DeSilva & Vinod P. Shah. (2019) Report on the AAPS Immunogenicity Guidance Forum. The AAPS Journal 21:4.
Crossref
Yuhong Xiang, Chuenlei Parng, Katrina Olson, Elena Seletskaia, Boris Gorovits, Darshana Jani, Teresa Caiazzo, Alison Joyce & Jean Donley. (2019) Neutralizing Antibody Assay Development with High Drug and Target Tolerance to Support Clinical Development of an Anti-TFPI Therapeutic Monoclonal Antibody. The AAPS Journal 21:3.
Crossref
Kazuko Nishimura, Hiroko Shibata, Muneo Aoyama, Jun Hosogi, Kenta Kadotsuji, Kyoko Minoura, Tamiki Mori, Takahiro Nakamura, Kazuhiro Nishimiya, Tatsuki Nomura, Tetsu Saito, Masako Soma, Hiroki Wakabayashi, Norihisa Sakamoto, Shingo Niimi, Noriko Katori, Yoshiro Saito & Akiko Ishii-Watabe. (2019) Elucidation of the statistical factors that influence anti-drug antibody cut point setting through a multi-laboratory study. Bioanalysis 11:6, pages 509-524.
Crossref
Joanne Goodman, Simon Cowen, Viswanath Devanarayan, David Egging, Thomas Emrich, Michaela Golob, Daniel Kramer, Jim McNally, James Munday, Robert Nelson, João A Pedras-Vasconcelos, Timo Piironen, Denise Sickert, Venke Skibeli, Marianne Scheel Fjording & Philip Timmerman. (2018) Feedback from the European Bioanalysis Forum: focus workshop on current analysis of immunogenicity: best practices and regulatory hurdles. Bioanalysis 10:4, pages 197-204.
Crossref
Jianchun Zhang, Wenjia Li, Lorin K. Roskos & Harry Yang. (2017) Immunogenicity assay cut point determination using nonparametric tolerance limit. Journal of Immunological Methods 442, pages 29-34.
Crossref
Jianchun Zhang & Robert J. Kubiak. 2016. Nonclinical Statistics for Pharmaceutical and Biotechnology Industries. Nonclinical Statistics for Pharmaceutical and Biotechnology Industries 263 294 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.